Mergers and acquisitions, operational rationalization and stock repurchasing will only sustain a company’s bottom line for so long. At some point, healthcare spending levels, even in the United States, will negatively impact price and reimbursement, thus reinstating unit…
Hey Western Pharma, Scrambling for Real Growth? Revisit the China Opportunity
November 25, 2015 | Category: Blog | Tags: Contract manufacturing China, drug manufacturing in China, Sterile Injectables China
China’s Pilot Program Opens Door to Contract Drug Manufacturing
Fresh off launching our company at the CPhI Worldwide Congress in Madrid in October, PaizaBio began business development efforts as the aseptic CMO partner of choice for Western pharmaceutical companies seeking to expand their presence in the burgeoning…
November 18, 2015 | Category: Blog | Tags: Aseptic drug manufacturing China, Chinese CMO, Sterile Injectables China